FORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Syncromune®, Inc., a clinical-stage biopharmaceutical company pioneering SYNC-T, an in situ personalized combination ...

Aspirin is another common anti-inflammatory medicine, and omega-3s are nutrients found in fish and nuts that are good for the ...

Osvyrti and Jubereq are FDA-approved denosumab biosimilars for osteoporosis and cancer-related skeletal events, ...

Regeneron announced the FDA’s approval of two indications of Eylea HD, including an 8mg injection for patients with macular ...

Former President Joe Biden has sparked dementia fears after he appeared "confused" at ex-Vice President Dick Cheney's funeral ...

Accord BioPharma, Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on development of oncology, immunology, and critical care therapies, announced today the U.S. Food and Drug ...

An investigator-developed drug has shown preclinical efficacy and is worth testing in clinical trials in aggressive breast ...

C OVID-19 mRNA vaccines that saved millions of lives globally during the pandemic from 2021 onwards, have now been reported ...

The company said, “Highlights from Moderna’s (MRNA) approved vaccines and prioritized portfolio include: Seasonal Vaccines: Spikevax: Approved in ...

Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026Expects to expand seasonal vaccine franchise from three to up to six approved products ...

Vision Healthcare ("Vision"), a fast-growing European consumer healthcare platform, recently completed acquisitions of Svenskt Kosttillskott ("Svenskt"), a leading Swedish e-commerce player for health ...